Correct option is (c) Drugs with narrow therapeutic indices
The best I can explain: The transdermal route is unsuitable when the drug dose is large when the drug has a large molecular size, the drug is skin sensitizing and irritating. It also becomes a problem when the drug is metabolized in the skin, the drug goes protein binding in the skin, or even if the drug is highly lipophilic or hydrophilic.